BRIEF published on 10/27/2025 at 23:05, 10 months 14 days ago Navion Capital II Proposes Qualifying Transaction with Maple Brain Healthcare TSX Venture Exchange Qualifying Transaction AI In Healthcare Navion Capital Maple Brain Healthcare
BRIEF published on 10/27/2025 at 23:05, 10 months 14 days ago Navion Capital II propose une transaction admissible avec Maple Brain Healthcare Bourse De Croissance TSX Transaction Admissible L'IA Dans Le Secteur De La Santé Navion Capital Soins De Santé Maple Brain
PRESS RELEASE published on 10/27/2025 at 23:00, 10 months 14 days ago Navion Capital II Announces Proposed Qualifying Transaction With Maple Brain Healthcare Inc. Navion Capital II Inc. and Maple Brain Healthcare Inc. announce non-binding LOI for Proposed Transaction involving AI software and medical device company. Maple Brain plans SAFE financing Medical Device AI Software Navion Capital II Inc. SAFE Financing Maple Brain Healthcare Inc.
BRIEF published on 02/29/2024 at 18:27, 2 years 6 months ago Navion Capital II Announces Completion of Initial Public Offering TSX Venture Exchange IPO Qualifying Transaction Navion Capital II Inc. Capital Pool Company
BRIEF published on 02/29/2024 at 18:27, 2 years 6 months ago Navion Capital II annonce la finalisation de son introduction en bourse Bourse De Croissance TSX Introduction En Bourse Navion Capital II Inc. Société De Capital De Démarrage Transaction Admissible
PRESS RELEASE published on 02/29/2024 at 18:22, 2 years 6 months ago Navion Capital II Announces Completion of Initial Public Offering Navion Capital II Inc. completes IPO, listing on TSXV as a Capital Pool Company. Offering of 2,500,000 common shares at $0.10 per share raises $250,000. PI Financial Corp. acts as agent TSXV IPO Navion Capital II Inc. Capital Pool Company PI Financial Corp.
Published on 09/11/2026 at 04:00, 5 hours 28 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 3 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 8 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 28 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:05, 22 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 28 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 09:00, 28 minutes ago Mountain Alliance AG invests in Evolved Aerospace and expands its involvement in the European defence technology market
Published on 09/11/2026 at 07:00, 2 hours 28 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 28 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 28 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 58 minutes ago Availability of the 2026 Interim Financial Report
